- Report
- June 2024
- 200 Pages
Global
From €7130EUR$7,950USD£6,168GBP
- Report
- November 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,134GBP
- Report
- November 2023
- 30 Pages
Global
From €2466EUR$2,750USD£2,134GBP
- Report
- December 2022
- 44 Pages
Global
From €1794EUR$2,000USD£1,552GBP
- Report
- September 2022
- 78 Pages
Global
From €1794EUR$2,000USD£1,552GBP
- Report
- January 2024
- 73 Pages
Global
From €3500EUR$4,181USD£3,134GBP
- Report
- October 2025
- 96 Pages
Global
From €3500EUR$4,181USD£3,134GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$4,181USD£3,134GBP
- Report
- January 2024
- 104 Pages
Global
From €3500EUR$4,181USD£3,134GBP
- Report
- September 2025
Global
From €3139EUR$3,500USD£2,715GBP
From €116EUR$129USD£100GBP
- Report
- October 2024
Global
From €3139EUR$3,500USD£2,715GBP
- Report
- October 2024
Global
From €3139EUR$3,500USD£2,715GBP

Vancomycin is an antibiotic used to treat a wide range of bacterial infections. It is a glycopeptide antibiotic, derived from the bacterium Amycolatopsis orientalis, and is used to treat infections caused by Gram-positive bacteria. Vancomycin is often used as a last-resort antibiotic, when other antibiotics have failed to treat an infection. It is also used to treat infections caused by Clostridium difficile, a bacterium that can cause severe diarrhea.
Vancomycin is available in both oral and intravenous forms, and is used to treat a variety of infections, including skin and soft tissue infections, bone and joint infections, and endocarditis. It is also used to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
Vancomycin is a widely used antibiotic, and is available from a number of pharmaceutical companies, including Pfizer, Merck, and AstraZeneca. It is also available in generic form from a number of generic drug manufacturers. Show Less Read more